 The fact that beneficiaries on Social Security Extra Help/LIS were never affected by the gap and the fact that many state pharmaceutical assistance programs protected middle income seniors in the gap are the reasons this gap benefit was never especially popular.Major Part D plan sponsors are dropping their more expensive options, and developing lower-cost ones.One option for those struggling with drug costs is the low-income subsidy.